International Journal of Radiation Oncology*Biology*Physics
Volume 77, Issue 4, 15 July 2010, Pages 969-973
EditorialReports of Unexpected Late Side Effects of Accelerated Partial Breast Irradiation—Radiobiological Considerations
References (29)
- et al.
Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation
Int J Radiat Oncol Biol Phys
(2009) - et al.
Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation
Int J Radiat Oncol Biol Phys
(2010) - et al.
Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial
Lancet Oncol
(2006) - et al.
Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial
Radiother Oncol
(2005) - et al.
ASTRO plenary: Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: Results from Radiation Therapy Oncology Group 8313
Int J Radiat Oncol Biol Phys
(1991) - et al.
Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: Clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy
Radiother Oncol
(1996) - et al.
Is the experience with CHART compatible with experimental data? A new model of repair kinetics and computer simulations
Radiother Oncol
(1992) - et al.
Does the interval between fractions matter in the range 4–8 h in radiotherapy? A study of acute and late human skin reactions
Radiother Oncol
(1995) - et al.
Repair capacity and kinetics of human skin during fractionated radiotherapy: Erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up
Radiother Oncol
(1989) - et al.
Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer
Radiother Oncol
(1999)
Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study
Radiother Oncol
(1989)
A 5-fraction regimen of adjuvant radiotherapy for women with early breast cancer: first analysis of the randomised UK FAST trial (ISRCTN62488883, CRUKE/04/015)
EJC Supplements
(2009)
Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: A study based on the EORTC Trial 22881-10882 “boost versus no boost”
Eur J Cancer
(2008)
Dose and volume effects on fibrosis after breast conservation therapy
Int J Radiat Oncol Biol Phys
(1994)
Cited by (65)
Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial
2022, Clinical and Translational Radiation OncologyCitation Excerpt :In the MGH and NCC experiences, daily dose delivered ranged from 6 to 8 Gy (4 Gy(RBE) BID). [27–29] Large fraction size and inadequate recovery time between fractions can increase risk of late effects [55], which, in combination with the number of fields treated per fraction, may worsen cosmesis. However, in the Mutter et al study, even with 9.3 Gy(RBE) fractions, favorable early outcomes was reported, possibly due to ample recovery between daily fractions and use of two-field plans. [33]
Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee
2021, International Journal of Radiation Oncology Biology PhysicsOnce Daily Versus Twice Daily External Beam Accelerated Partial Breast Irradiation: A Randomized Prospective Study
2021, International Journal of Radiation Oncology Biology PhysicsAccelerated Partial Breast Radiation: Information on Dose, Volume, Fractionation, and Efficacy from Randomized Trials
2020, International Journal of Radiation Oncology Biology Physics
Conflict of interest: none.
Copyright © 2010 Elsevier Inc. All rights reserved.